NCT03150862 2025-02-04
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
Phase 1/2 Completed
BeiGene
National Cancer Institute (NCI)
Children's Oncology Group
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC